Collagenase, Type 2, Filtered Reference: 252-10117 Collagenase, Type 2, which is filtered through a 0.22 micron membrane and lyophilized in vials.
KM 233 Reference: 10640-10 Δ8-THC analog with 13-fold selectivity for the CB2 receptor (Kis = 12.3 and 0.91 nM, for CB1 and CB2 respectively); its CB agonist activity inhibits human U87 glioma cell proliferation in vitro ( IC50 = 1.4 μM) and in vivo (2 mg/kg in a SCID mouse xenograft side-pocket model)
Collagenase, Type 3 Reference: 252-10118 Lower in secondary proteolytic contaminant activities but with typical collagenase activity. Suggested for mammary primary cell isolation. A dialyzed, lyophilized powder.
KM 233 Reference: 10640-25 Δ8-THC analog with 13-fold selectivity for the CB2 receptor (Kis = 12.3 and 0.91 nM, for CB1 and CB2 respectively); its CB agonist activity inhibits human U87 glioma cell proliferation in vitro ( IC50 = 1.4 μM) and in vivo (2 mg/kg in a SCID mouse xenograft side-pocket model)
Collagenase, Type 3, Filtered Reference: 252-10119 Collagenase, Type 3, which is filtered through a 0.22 micron membrane and lyophilized in vials.
KM 233 Reference: 10640-5 Δ8-THC analog with 13-fold selectivity for the CB2 receptor (Kis = 12.3 and 0.91 nM, for CB1 and CB2 respectively); its CB agonist activity inhibits human U87 glioma cell proliferation in vitro ( IC50 = 1.4 μM) and in vivo (2 mg/kg in a SCID mouse xenograft side-pocket model)